On Sept. 10, 2019, the Federal Trade Commission (FTC) issued warning letters to three undisclosed companies regarding their marketing claims on cannabidiol (CBD) products. The FTC claimed that each company made various...more
Cannabidiol (CBD) products increasingly are showing up in the mainstream market and taking many forms, including CBD-infused beverages, chocolates, and even beauty products. CBD, a plant-based compound naturally occurring in...more
In December 2018, Congress made significant changes to the Farm Bill, which legalizes industrial hemp. It also removes hemp-derived products such as cannabidiol (CBD) from Schedule I status under the Controlled Substances...more
U.S. Department of Health and Human Services Secretary Alex Azar announced this month the publication of a Final Rule from the Centers for Medicare & Medicaid Services (CMS) that will require television advertisements for...more
The next in our series of posts sharing key takeaways from panels at the Healthcare & Life Sciences Private Equity and Lending Conference discusses dermatology investing. It is authored by our colleagues Royce DuBiner,...more
The next in our series of posts sharing key takeaways from panels at the Healthcare & Life Sciences Private Equity and Lending Conference focuses on investing in surgical specialty practices.
***
Investment and...more